Molina Healthcare, Inc. logo MOH - Molina Healthcare, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 15
SELL 6
STRONG
SELL
0
| PRICE TARGET: $169.75 DETAILS
HIGH: $224.00
LOW: $124.00
MEDIAN: $160.50
CONSENSUS: $169.75
DOWNSIDE: 7.81%

Stock News

Molina: Q1 Beat Proves The Cost Story, Now Comes Hard Decision For The Management

Molina: Q1 Beat Proves The Cost Story, Now Comes Hard Decision For The Management

Molina Healthcare (MOH) remains rated Hold as clarity on post-MAPD cost structure and market share recovery is still pending. MOH's exit from Medicare Advantage removes $1B in unprofitable revenue, improving business quality but shrinking the top line. 2026 guidance is reaffirmed at $42B premium revenue and at least $5.00 adjusted EPS, with underlying normalized earnings power closer to $7.50 per share.

Apr 24, 2026 04:30 AM seekingalpha.com
Molina Healthcare Reports First Quarter 2026 Financial Results

Molina Healthcare Reports First Quarter 2026 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2026 GAAP income per diluted share of $0.27 and adjusted income per diluted share of $2.35. Financial results are summarized below:   Three months ended   March 31,   2026   2025         (In millions, except per-share results) Premium Revenue $10,172   $10,628 Total Revenue $10,796   $11,147         GAAP:       Net Income $14   $298 EPS – Diluted $0.27   $5.45 Medical Care Ratio.

Apr 22, 2026 12:15 PM businesswire.com

Price Targets